$ Value
$10.8M
Shares
48,782
Price
$221
Filed
Jan 28
Insider
Name
Duato Joaquin
Title
CEO and Chairman of the Board
CIK
0001673401
Roles
Transaction Details
Transaction Date
2026-01-26
Code
S
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
30,852
Footnotes
This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2025).
Filing Info
Duato Joaquin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | F | $390K |
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | F | $477K |
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | A | $0 |
| 2026-02-15 | JNJ | A | $0 |
| 2026-02-13 | JNJ | M | $0 |
| 2026-02-13 | JNJ | F | $242K |
Other Insiders at JNJ (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
REED JOHN C
EVP, Innovative Medicine, R&D
|
— | $13.1M | 2026-02-17 |
|
Duato Joaquin
CEO and Chairman of the Board
|
— | $11.3M | 2026-02-15 |
|
Wolk Joseph J
Exec VP, CFO
|
— | $21.8M | 2026-02-17 |
|
Taubert Jennifer L
EVP, WWC. Innovative Medicine
|
— | — | 2026-02-15 |
|
Wengel Kathryn E
EVP, Chief TO and Risk Officer
|
— | — | 2026-02-15 |
|
Decker Robert J
VP Corporate Controller
|
— | — | 2026-02-15 |
|
Swanson James D.
EVP, CIO
|
— | $15.1M | 2026-02-17 |
|
Broadhurst Vanessa
EVP, Global Corp Affairs
|
— | $1.5M | 2026-02-17 |
|
Forminard Elizabeth
EVP, Chief Legal Officer
|
— | — | 2026-02-15 |
|
Schmid Timothy
EVP, WW Chair, MedTech
|
— | $5.5M | 2026-02-18 |
|
Mulholland Kristen
EVP, Chief HR Officer
|
— | — | 2026-02-15 |